DrugPatentWatch Database Preview
US Patent Family Members and Approved Drugs for United States of America Patent: 2017281721
» See Plans and Pricing
US Patent Family Members and Approved Drugs for United States of America Patent: US2017281721
US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|
Start Trial | 2034-09-12 | urokinase | Microbix Biosystems | KINLYTIC |
Start Trial | 2034-09-12 | asparaginase | Merck | ELSPAR |
Start Trial | 2034-09-12 | interferon alfa-2b | Schering | INTRON A |
Start Trial | 2034-09-12 | interferon alfa-n3 | Interferon Sciences | ALFERON N INJECTION |
Start Trial | 2034-09-12 | aldesleukin | Chiron | PROLEUKIN |
Start Trial | 2034-09-12 | filgrastim | Amgen | NEUPOGEN |
Start Trial | 2034-09-12 | sargramostim | Berlex Labs | LEUKINE |
>US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |